Travel pass: Pros may outweigh cons
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
Krishna M Ella, CMD, Bharat Biotech - Mohammed_Yousuf
Developing a vaccine is the only way to tackle Covid19, according to Krishna M Ella, Chairman and Managing Director, Bharat Biotech International.
“There are many promising treatments being studied thoroughly all over the world, although only a vaccine should be considered as a long-term strategy to combat Covid,’’ Ella told BusinessLine.
International collaboration is also vital for developing a vaccine, according to Ella.
Bharat Biotech had recently announced that it was in the process of developing a vaccine, CoroFlu, for Covid-19.
“Even for CoroFlu, we have applied a similar approach — which is an international collaboration of virologists at the University of Wisconsin–Madison and vaccine maker FluGen,’’ he said.
“Our approach is to develop a vaccine, which is very easy to deliver even by an anganwadi worker. We are also optimistic that CoroFlu will protect patients from both the flu virus and the novel coronavirus. The vaccine is targeted at the critical adult population,’’ he said.
When asked about the probable timeline for getting the vaccine ready, Ella said efforts are on at the UW-Madison’s Influenza Research Institute to assess CoroFlu’s safety and efficacy in animal models .
The testing in laboratory animal models and development of the vaccine is expected to take approximately four-six months. CoroFlu may be used in human clinical trials by the fall of 2020, he said.
According to Ella, the best way to deal with the virus threat is to “adhere and respect the lock-down and practice safe distancing.’’
“Wash your hands and wear a mask when you go out. Talk to your doctor and follow his advice as well as the treatment protocol,’’ he said.
Bharat Biotech has so far successfully developed 10 different viral vaccines. It has delivered more than 5 billion doses of viral vaccines, including anti-rabies vaccine after the acquisition of Chiron Behring from GSK.
It has also supplied 80 per cent of polio vaccine for the Indian government’s national immunisation programme.
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
A 2010 Act to regulate the medical sector flounders in implementation, even as healthcare remains ...
The scheme to boost local medtech manufacturing is timely, especially given the raging pandemic. But ...
Do pilots sleep on their job?
Fiscal stimulus, friendly monetary policy and firm commodity prices point towards normalcy, says the MD and ...
Price correction is a good opportunity for long-term investors to take the plunge
Q4 earnings, along with progress in controlling Covid-19 spread, will be in focus
Do keep in mind that premium may go up in case one of the members has a pre-existing condition
In an age of falling female workforce participation, worsened by the Covid-19 pandemic, policy makers and ...
Of an injured baby goat, young men on motorcycles and political tensions
It’s the birthday of Muttiah Muralitharan — the man who took a staggering 800 test wickets. What better way to ...
An ode to writer and great-uncle Ved Mehta, and Ekarat, the friend who wrote and quit on his own terms
Monotype’s 2021 type trends report points to a return to hand and the familiar
As ‘ear-points’ between a company and a customer grow, we are witnessing a rise in audio assets
‘Desi Twitter challenger’ Koo on connecting like-minded folks
Coca-Cola has just introduced an oat milk line in the US under its Simply brand. Smart move, say industry ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor